Lecanemab

4 trials

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

0 Recruiting

4 Completed trials

2 Sponsors

7 Countries

Phase III

Phase II/III

Phase III/IV

Phase III: 2 Phase II/III: 1 Phase III/IV: 1

Indications tested

Prodromal Alzheimer's disease 1

Sponsors using this IMP

Eisai Limited 2 Washington University School Of Medicine 2

All trials

4 total

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Early… Ended

2024-515198-91-00 Phase II/III 5 countries Washington University School Of Medicine
AHEAD 3-45 Study: A Clinical Study to Investigate the Effects of BAN2401 in Subjects With Preclinical Alzheimer’s Disease Ended

2024-510888-39-00 Phase III 1 country Eisai Limited
A Phase 3 clinical study to investigate the effects of BAN2401 in patients with Early Alzheimer's Disease. Ended

2024-510887-22-00 Phase III 5 countries Eisai Limited
The Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Amyloid Removal Trial (ART): A Phase IIIb/IV Open-Label Study of Lecanemab … Ended

2024-513458-31-00 Phase III/IV 1 country Washington University School Of Medicine

Showing 1–4 of 4 trials

← All drugs A–Z